Eczema in women often flares in patterns that track hormonal shifts: the week before menstruation, during pregnancy (particularly the first and third trimesters), and through the perimenopausal window. The mechanisms differ (progesterone sensitising the skin's mast cells, oestrogen declines reducing ceramide production, pregnancy altering immune polarisation), but the practical response overlaps: tighter barrier support, more careful trigger control during the vulnerable windows, and different treatment constraints during pregnancy and breastfeeding.
The menstrual cycle
Up to half of women with atopic eczema report that flares cluster in the luteal phase, the week before menstruation. The commonest presentation is increased itch starting four to seven days before the period, with visible worsening of existing flare sites in the 48 hours before bleeding starts.
The mechanism is partly progesterone hypersensitivity: progesterone peaks in the luteal phase and can directly sensitise mast cells, increasing histamine release. There's also a premenstrual drop in oestrogen, which reduces ceramide synthesis and briefly compromises the skin barrier. Both effects are small individually but they compound.
Practical response: track symptoms alongside cycle days for two or three full cycles using a simple tracking method. Once the pattern is confirmed, pre-empt the luteal window: increase emollient frequency from day 21 of your cycle, avoid obvious triggers (alcohol, high-histamine foods, stress) more strictly in that window, and have a short steroid course pre-prepared so you can respond early rather than after three days of worsening.
Pregnancy
Pregnancy affects eczema in both directions and the pattern is individual. Roughly half of women with pre-existing atopic dermatitis experience worsening during pregnancy, while a smaller fraction improve. Women without a history of eczema can also develop "atopic eruption of pregnancy", the most common pregnancy-specific dermatosis.
The mechanism is a shift in immune polarisation: pregnancy increases Th2-dominant immune activity, which is the same axis driving atopic dermatitis. This means existing flares can intensify and new-onset eczema can appear, particularly in the first and third trimesters.
Treatment during pregnancy has specific constraints. Emollients are fine and their use should increase. Low-to-mid potency topical steroids (hydrocortisone 1%, mometasone, betamethasone valerate) are considered safe in pregnancy when used in normal doses for normal durations, and withholding them usually harms more than it helps because untreated flares lead to scratching, sleep loss, and secondary infection. Avoid potent steroids over large body areas and avoid oral steroids unless prescribed specifically by a doctor aware of the pregnancy.
Avoid topical calcineurin inhibitors (tacrolimus, pimecrolimus) during pregnancy without specialist guidance, avoid oral ciclosporin and methotrexate, and discuss any new systemic treatment, including dupilumab, with a dermatologist rather than starting without supervision.
Breastfeeding
Breastfeeding commonly triggers nipple and areolar eczema from repeated friction, saliva exposure, and moisture. The protocol: a thin layer of fragrance-free emollient after each feed, careful latch (which reduces friction damage), and if a true eczema flare develops, a short course of a low-potency topical steroid applied immediately after feeding and wiped off before the next feed. Hydrocortisone 1% for no more than seven days is the standard starting point.
If the area becomes cracked, sharply painful, or develops yellow crust, it's worth checking for thrush, bacterial infection, or a specific latch issue alongside the eczema.
Perimenopause
In the decade before menopause, declining oestrogen reduces ceramide production, thins the epidermis, and increases transepidermal water loss. For women with atopic predisposition this often presents as new-onset or returning eczema in the forties and fifties, sometimes many years after a previous atopic phase in childhood.
The presentation is typically drier than classic atopic dermatitis: fine cracks and persistent low-grade itch on the lower legs, forearms, and trunk, rather than the weeping inflamed patches of childhood eczema. It overlaps with pure xerosis (dry skin) and is often dismissed as such.
Response: heavier, lipid-rich emollients applied twice daily, particularly immediately after showering. Ceramide content matters here more than in younger women because the underlying deficit is ceramide production. Short courses of topical steroid to break active flares, but the primary management is consistent moisturisation.
Hormone replacement therapy (HRT) has a mixed and individual effect on eczema. Some women report substantial improvement within three months of starting oestrogen-containing HRT, consistent with the ceramide-production mechanism. Others see no change. It's reasonable to flag eczema in a conversation about HRT but not a primary reason to start or avoid it.
When to investigate the hormonal component
Suspect a hormonal component when: flares cluster within a specific week of the cycle; new-onset eczema appears during pregnancy, immediately postpartum, or in the mid-forties; or eczema worsens markedly on starting or stopping hormonal contraception. Two to three cycles of careful tracking usually confirms or rules out the pattern.
If confirmed, it doesn't change the underlying treatment (barrier repair, trigger avoidance, short steroid courses for flares) but it changes the timing and the baseline intensity of barrier support in the vulnerable windows. And it's worth knowing, because "my eczema is getting worse and I don't know why" is frustrating to live with; "my eczema tracks the luteal phase and I can pre-empt it" is a much more workable frame.
Reviewed by the xmahub protocol team. Based on peer-reviewed dermatology literature.